Search Results

There are 4491 results for: content related to: New lipid-lowering drugs: an update

  1. You have free access to this content
    Recent developments in prostate cancer biomarker research: therapeutic implications

    British Journal of Clinical Pharmacology

    Volume 71, Issue 2, February 2011, Pages: 157–174, Sujitra Detchokul and Albert G. Frauman

    Article first published online : 28 JUL 2010, DOI: 10.1111/j.1365-2125.2010.03766.x

  2. Acupuncture for (sub)acute non-specific low-back pain

    Intervention Protocol

    The Cochrane Library

    Andrea D Furlan, Fatemeh Yazdi, Alexander Tsertsvadze, Lixing Lao, Karen Sherman, Carlo Ammendolia, Ellen Wang, Byung-Cheul Shin, Ikuro Wakayama and Maurits W van Tulder

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD009265

  3. You have free access to this content
    Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors

    International Journal of Cancer

    Volume 133, Issue 4, 15 August 2013, Pages: 788–796, Robert A. Figlin, Isabelle Kaufmann and Jillian Brechbiel

    Article first published online : 12 FEB 2013, DOI: 10.1002/ijc.28023

  4. Immune modulation for treatment of allergic disease

    Immunological Reviews

    Volume 242, Issue 1, July 2011, Pages: 258–271, Tran-Hoai T. Nguyen and Thomas B. Casale

    Article first published online : 20 JUN 2011, DOI: 10.1111/j.1600-065X.2011.01034.x

  5. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Article first published online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  6. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

    Cancer

    Jayson I. L. Bastien, Katharine A. McNeill and Howard A. Fine

    Article first published online : 23 SEP 2014, DOI: 10.1002/cncr.28968

  7. Role of targeted therapy in the treatment of advanced prostate cancer

    BJU International

    Volume 105, Issue 6, March 2010, Pages: 748–767, Karim Fizazi, Cora N. Sternberg, John M. Fitzpatrick, R. William Watson and Majid Tabesh

    Article first published online : 25 FEB 2010, DOI: 10.1111/j.1464-410X.2010.09236.x

  8. New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 975–1016, Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich and Jennifer A. Campbell

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.10.975

  9. FMS Kinase Inhibitors: Current Status and Future Prospects

    Medicinal Research Reviews

    Volume 33, Issue 3, May 2013, Pages: 599–636, Mohammed I. El-Gamal, Hanan S. Anbar, Kyung Ho Yoo and Chang-Hyun Oh

    Article first published online : 20 MAR 2012, DOI: 10.1002/med.21258

  10. You have free access to this content
    Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 31–42, Phillip PARENTE, Francis PARNIS and Howard GURNEY

    Article first published online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01506.x

  11. New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Article first published online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  12. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Article first published online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  13. You have free access to this content
    Recent advances in the pathophysiology and pharmacological treatment of obesity

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 525–535, P. K. Chugh and S. Sharma

    Article first published online : 29 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01347.x

  14. You have full text access to this OnlineOpen article
    Making progress: preserving beta cells in type 1 diabetes

    Annals of the New York Academy of Sciences

    Volume 1243, Issue 1, December 2011, Pages: 119–134, Mary Pat Gallagher, Robin S. Goland and Carla J. Greenbaum

    Article first published online : 23 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06321.x

  15. You have free access to this content
    Smoldering multiple myeloma: present position and potential promises

    European Journal of Haematology

    Volume 92, Issue 1, January 2014, Pages: 1–12, Nishant Tageja, Elisabet E. Manasanch, Neha Korde, Mary Kwok, Sham Mailankody, Manisha Bhutani, Mark Roschewski and Ola Landgren

    Article first published online : 26 NOV 2013, DOI: 10.1111/ejh.12205

  16. You have free access to this content
    MicroRNAome genome: A treasure for cancer diagnosis and therapy

    CA: A Cancer Journal for Clinicians

    Volume 64, Issue 5, September/October 2014, Pages: 311–336, Ioana Berindan-Neagoe, Paloma del C. Monroig, Barbara Pasculli and George A. Calin

    Article first published online : 7 AUG 2014, DOI: 10.3322/caac.21244

  17. When should FDG-PET be used in the modern management of lymphoma?

    British Journal of Haematology

    Volume 164, Issue 3, February 2014, Pages: 315–328, Sally Fiona Barrington and Nabegh George Mikhaeel

    Article first published online : 17 OCT 2013, DOI: 10.1111/bjh.12601

  18. Multiple Sclerosis Therapeutic Pipeline: Opportunities and Challenges

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 192–206, Stephen Krieger

    Article first published online : 21 MAR 2011, DOI: 10.1002/msj.20241

  19. Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

    Annals of the New York Academy of Sciences

    Volume 1263, Issue 1, August 2012, Pages: 43–56, Ira V. Gupta and Roxanne C. Jewell

    Article first published online : 25 JUL 2012, DOI: 10.1111/j.1749-6632.2012.06661.x

  20. Plant and Marine Sources

    Natural Products Analysis: Instrumentation, Methods, and Applications

    Amedeo Amedei, Elena Niccolai, Pages: 43–113, 2014

    Published Online : 19 SEP 2014, DOI: 10.1002/9781118876015.ch4